Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment

A 45-year-old Italian woman, affected by relapsing–remitting multiple sclerosis (RR-MS) starting from 2011, started treatment with alemtuzumab in July 2016. Nine months after the second infusion, she had an immune thrombocytopenic purpura (ITP) with complete recovery after steroid treatment. Three m...

Descripción completa

Detalles Bibliográficos
Autores principales: Buscarinu, Maria Chiara, Fornasiero, Arianna, Pellicciari, Giulia, Reniè, Roberta, Landi, Anna Chiara, Bozzao, Alessandro, Cappelletti, Cristina, Bernasconi, Pia, Ristori, Giovanni, Salvetti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895826/
https://www.ncbi.nlm.nih.gov/pubmed/31671619
http://dx.doi.org/10.3390/brainsci9110299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895826/
https://www.ncbi.nlm.nih.gov/pubmed/31671619
http://dx.doi.org/10.3390/brainsci9110299

Ejemplares similares